PAMELA CASEY: Open Payments
NPI 1831598051 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 4 payments from 4 companies in 2025. Trend: 2023 $1,024 · 2024 $588 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $124 |
| Neurelis, Inc. | 1 | $121 |
| Boston Scientific Corporation | 1 | $112 |
| Janssen Pharmaceuticals, Inc | 1 | $97 |
Products named: VALTOCO, WaveWriter Alpha Prime 16, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
